Cetera Investment Advisers lifted its stake in Cabot Co. (NYSE:CBT - Free Report) by 60.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,241 shares of the specialty chemicals company's stock after acquiring an additional 7,235 shares during the period. Cetera Investment Advisers' holdings in Cabot were worth $1,757,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in CBT. R Squared Ltd bought a new position in shares of Cabot in the 4th quarter worth $26,000. EverSource Wealth Advisors LLC increased its position in Cabot by 37.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after buying an additional 219 shares in the last quarter. Manchester Capital Management LLC increased its position in Cabot by 1,685.1% during the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after buying an additional 1,584 shares in the last quarter. KBC Group NV increased its position in Cabot by 43.1% during the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock valued at $187,000 after buying an additional 616 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC acquired a new position in Cabot during the 4th quarter valued at about $205,000. 93.18% of the stock is owned by institutional investors.
Cabot Stock Performance
Shares of CBT stock traded up $0.02 during mid-day trading on Monday, reaching $74.07. The stock had a trading volume of 450,376 shares, compared to its average volume of 408,635. The business's fifty day moving average is $78.25 and its 200-day moving average is $88.24. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. The firm has a market cap of $3.98 billion, a price-to-earnings ratio of 9.84, a PEG ratio of 0.74 and a beta of 0.91. Cabot Co. has a 1-year low of $71.64 and a 1-year high of $117.46.
Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share for the quarter, beating analysts' consensus estimates of $1.86 by $0.04. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $1.02 billion. Cabot had a return on equity of 26.79% and a net margin of 10.60%. The company's revenue was down 8.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.78 earnings per share. On average, research analysts forecast that Cabot Co. will post 7.57 earnings per share for the current year.
Cabot Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be paid a $0.45 dividend. This is an increase from Cabot's previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Friday, May 30th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.43%. Cabot's dividend payout ratio is presently 23.29%.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on CBT. Wall Street Zen lowered Cabot from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. UBS Group reduced their target price on Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research report on Monday, April 7th. Finally, JPMorgan Chase & Co. reduced their target price on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st.
Get Our Latest Stock Analysis on CBT
Cabot Company Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.